Research & Reports

Informative research and reports produced by CWHP and aimed at improving our understanding of workforce health and performance, including how to support and improve it.

Work: The Good, The Bad and The Precarious

miniature workers and coins

In response to the Business Roundtable press release of August 19, 2019, CWHP reviews the good, the bad and the precarious nature of work today in this Blog Article from October, 2019.  As the future of work shifts to a new economic reality for workers, an array of policy and practice solutions should be tried that protect worker health, wellbeing and income security.  Whether such solutions are tried by employers, states, or other entities, we need accountability mechanisms and reliable measurement to understand whether the results we desire are achieved. Let's hold ourselves accountable for creating that economic security!  

We would like to hear your ideas on how more supportive work can become a reality.  Send us your thoughts.

Resource
Healthy Work Agenda - Healthy Work Campaign

The Healthy Work Agenda is designed to promote understanding, discussions, and actions that advance “healthy work.” (See Principles of Healthy Work.) Created to support the Healthy Work Campaign, the Agenda is a set of actions to improve the quality of jobs and promote “healthy work.” Those actions are part of an effort to encourage “thinking …

Study Summary: Complex Case Management and New Technology

doctor connecting data

The Center for Workforce Health and Performance (CWHP) will study the outcomes of employee populations after pharmacogenomics are facilitated, case managed, and applied in high-risk, highly complex plan members. In addition to understanding the perspectives of patients and providers, this study will assess the clinical and cost-related outcomes associated with pharmacogenomics in employee populations through administrative data records.  For more information on study recruitment click here.

Peripheral Artery Disease and Work-related Outcomes

Cover page of CWHP Report on PAD and Work Outcomes

The CWHP report "The Association of Peripheral Artery Disease (PAD) with Work-related Outcomes" presents the results of a study comparing the impact of moderate to severe PAD with mild PAD along with other comorbidities on the incidence and duration of short-term work disability.

This report was partially funded through Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. The views presented in the report are solely the responsibility of the author and do not necessarily represent the views of the sponsoring organization nor collaborators on the study.

If PAD cases can be managed in a way that prevents mild cases from becoming moderate/severe then employees and employers may benefit from less work disruption due to fewer cases of short-term work disability. Key to success is a focus on complex case management and the other comorbidities that these patients may have. By adopting a patient-centered approach to prevention, treatment access and improved outcomes we should expect greater focus on functional and quality of life outcomes that matter to individuals. For those in the workforce, being able to attend work, perform well on the job and stay at work or return to work in a timely and healthy fashion should a period of work disability occur is critical for the continued physical and socioeconomic health of the individual and their contributions to corporate success.

Cancer and Work-related Outcomes

Cancer and Work Outcomes Report Cover

The CWHP report "Work-Related Outcomes Among Employees With Cancer" presents a selected summary of recent research on the importance of stay at work and return to work outcomes for workers with cancer as well as a descriptive analysis of short-term work disability experience across six types of cancer for a multi-employer population of workers.  

This report was partially funded through PhRMA. The views presented in the report are solely the responsibility of the author and do not necessarily represent the views of the sponsoring organization nor collaborators on the study.

Access to high quality and appropriate treatment for cancer may mitigate the effects of work performance loss and prevent longer term periods of work disability and income disruption. Support can also be offered through employee assistance programs including guidance around caregiver support for employees with family members who have cancer.  Employers, providers and data scientists can all support the inclusion of the right data, resources and treatment to affect longer, healthier and more fulfilling working lives for employees with cancer.

Population Health to Personalized Medicine: Connecting Disease Indicators to Work Outcomes - Diabetes

Report Cover Pop Health to Personalized Medicine_Diabetes

The CWHP report "Population Health to Personlized Medicine: Connecting Disease Indicators to Work Outcomes - Type 2 Diabetes" presents a framework for connecting disease indicators of diabetes to a variety of work outcomes including absence, job performance, work disability and permanent departure from the workforce. The framework outlines connections between clinical and employer perspectives around worker health and suggests a variety of ways to improve diagnosis and treatment for better health and work-related outcomes.

This series was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (#2970-CWHP). The views presented in this series are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.

If you would like to be involved in the development of reports, webinars and learning opportunities for this series -- Patient‐Centered Outcomes Research (PCOR) Dissemination at Work: How Employers Use Evidence to Make Employee Health Investment Decisions -- please contact Dr. Kimberly Jinnett at kjinnett@tcwhp.org.

 

AttachmentSize
PDF icon Diabetes & Work Outcomes_August 20181.25 MB

How Employers Use Evidence to Make Employee Health Investment Decisions

report cover with workers

The CWHP report "The Employer's Role in Using Research-Based Healthcare Evidence" presents findings and recommendations from a series of interviews with employers and their programmatic solutions partners.  

This series was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (#2970-CWHP). The views presented in this series are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.

If you would like to comment on pre-publication versions of content developed for this series -- Patient‐Centered Outcomes Research (PCOR) Dissemination at Work: How Employers Use Evidence to Make Employee Health Investment Decisions -- please contact Dr. Kimberly Jinnett at kjinnett@tcwhp.org.

Documents include an employer interview summary report and frameworks tracking clinical indicators to work outcomes for five groups (diabetes, depression, cancer, pain and multimorbidity). Look for webinars and other engagement opportunities to follow.

Resource
PCORI in Practice Webinar: Employers' Use of Patient-Centered Research - Webinar Recording - December 6, 2017

PCORI was pleased to join the Integrated Benefits Institute (IBI) and Center for Workforce Health and Performance (CWHP) to discuss employers' use of patient-centered research. During this webinar, leaders from three major employers discussed their perspective on how employers consider patient-centered research in the design and purchase of employee health benefits. (Read more)

Worker Well-being and High Performance Workplaces: Two Sides of the Same Coin

Small worker figurine standing on large coins

Worker well-being and high performance workplaces are fundamentally linked to each other; we argue that it is difficult to have one without the other.  Of course, how well-being and performance are defined is central to the argument of whether you truly can have one without the other.  What does it mean to have a high performance workplace?  How do we define and think about employee well-being and how it contributes to business value?  These and other topics are explored along with selected research and evidence on these topics.

Download the slide deck with notes presented at the 2nd International Symposium to Advance Total Worker Health held on May 9, 2018 in Bethesda Maryland.

Please contact Dr. Kimberly Jinnett at kjinnett@tcwhp.org if you have any questions or comments about this presentation.

Consumerism, Self-Care Trends and the Broader Value of Health

Consumerism and Health Value Report Image

A new CWHP report on Consumerism, Self-Care Trends and the Broader Value of Health suggests the importance of education and tools to assist individuals in making smart treatment decisions -- whether in the formal treatment system or through self-care alternatives. To hold down the costs of healthcare benefits, employers are exploring a variety of strategies aimed at making consumers more aware of the costs of their care in order to influence utilization of that care. Consumer guidance can help employees navigate to appropriate care, whether it is provided through the formal treatment system or through self-care including OTC alternatives. Broader work-related benefits including improved attendance and job performance and less work disability are associated with improved employee health. In light of the consumerism shift in health decision-making, consumer education and decision-support tools may support better choices resulting in improved outcomes for both employees and employers

Cancer in the Workplace - Supporting Treatment for Positive Employee and Employer Results

cancer cells

The big “C” – cancer — can cause panic and feelings of helplessness. These feelings, however, often are shared beyond the patients being screened or treated for the disease. Employers often are unsure of how to help their employees who have been diagnosed with cancer and desire to remain at work during treatment or return to work after care. Yet we know from existing research that having access to proper screening and high quality treatment can have positive effects on these employees’ work outcomes. Since chronic conditions (e.g., diabetes and obesity) and unhealthy lifestyles that contribute to cancer rates are on the rise while innovative cancer treatments are available employers would be wise to consider lessons learned on the topic of cancer in the workplace.

This session, moderated by IBI with practical insights from an employer and provider covered the following:

  • Importance of cancer prevention and treatment to work outcomes and the business imperative
  • CWHP’s recent analysis of cancer and work outcomes including discussion of innovative oncology treatments
  • Provider action – supporting employees during treatment to stay at and/or return to work during and after treatment
  • Employer action – one employer’s approach to supporting employees with cancer
  • Reflection on bringing in broader outcomes to further the business case

Musculoskeletal Disorders, Workforce Health and Productivity in the United States

Woman with Pain in Spine

 

This white paper summarizes what is known about musculoskeletal disorders (MSDs) in the United States and their relationship to employment. We review the major existing clinical, epidemiological and labour market evidence on the prevalence and impact of MSDs in the U.S. working-age population. Musculoskeletal disorders represent a group of conditions that affect the muscles, tendons, ligaments, joints, peripheral nerves and supporting blood vessels in the body. MSDs constitute a significant proportion of the disease burden in the United States and have substantial economic implications. Of particular interest to this paper is the impact that MSDs have on people of working age. The white paper draws on a literature review of the existing academic and grey literature looking at the prevalence and impact of MSDs on the labour market in the United States.

The detrimental effect that MSDs have on the U.S. workforce should not be underestimated, in terms of both economic costs to the employer and economic and social costs to the individual. As more employees are expected to work until they are older and obesity levels continue to rise, MSDs are set to become an even larger issue. There are clinical and workplace interventions that can counter this trend and lessen the burden of MSDs on the U.S. labour market.

AttachmentSize
PDF icon MSD and Work Outcomes_Report809.73 KB